RoheenaPanniMD

General Surgery • Saint Louis, MO

Surgical Oncology (Other than Breast)

Physician

Join to view full profile

Dr. Panni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Panni's full profile

Already have an account?

Office
10 Barnes West Dr
Ste 100
Saint Louis, MO 63141
Phone+1 314-747-0410

Fax+1 877-991-8954

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 2013 - 2018
Aga Khan Medical CollegeClass of 2011

Certifications & Licensure

MO State Medical License 2014 - 2025
NY State Medical License 2021 - 2024
IN State Medical License 2017 - 2019
American Board of Surgery Surgery
American Board of Surgery Complex General Surgical Oncology

Publications & Presentations

PubMed

520 citations
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic canc...
Timothy M. Nywening, Andrea Wang-Gillam, Dominic E. Sanford, Brian A. Belt, Roheena Z. Panni
The Lancet. Oncology. 2016-05-01
335 citations
Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal ade...
Timothy M. Nywening, Brian A. Belt, Darren R. Cullinan, Roheena Z. Panni, Booyeon J. Han
Gut. 2018-06-01
423 citations
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
Dominic E. Sanford, Brian A. Belt, Roheena Z. Panni, Allese Mayer, Anjali D. Deshpande
Clinical Cancer Research. 2013-07-01

Authored Content

Intestinal Resection-Associated Metabolic SyndromeMarch 2018
Intestinal Resection-Associated Metabolic SyndromeMarch 2018

Press Mentions

Immune-Boosting Compound Makes Immunotherapy Effective Against Pancreatic CancerJuly 17th, 2019
Immune-Boosting Compound Makes Immunotherapy Effective Against Pancreatic CancerJuly 3rd, 2019